Washington: Pfizer Inc and partner BioNTech SE's COVID-19 vaccine candidate produced no severe allergic reactions during clinical trials, a Pfizer…
New Delhi: Johnson & Johnson’s COVID-19 vaccine candidate’s late-stage study was paused as the company probes into a participant’s “unexplained…
New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has demonstrated protective efficacy and immunogenicity in non-human primates in Phase I…